Company Search:
Advanced Search
Sponsored Links
Cellavision AB Company Snapshot
Cellavision AB operates in the Electromedical equipment sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cellavision AB with three other companies in this sector in Sweden: Ortivus AB (2015 sales of 72.62 million Swedish Kronor [US$8.11 million] ), Boule Diagnostics AB (331.41 million Swedish Kronor [US$37.02 million] of which 34% was Instruments), and Arcoma AB (123.29 million Swedish Kronor [US$13.77 million] ).

Sales Analysis. Cellavision AB reported sales of SEK 239.39 million (US$26.74 million) for the year ending December of 2015. This represents an increase of 10.4% versus 2014, when the company's sales were SEK 216.92 million. Sales at Cellavision AB have increased during each of the previous five years (and since 2010, sales have increased a total of 82%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Cellavision AB
  Stock Performance Chart for Cellavision AB
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 94.25
(Figures in Swedish Kronor)
1 Week 10.2%   13 Weeks 12.2%  
4 Weeks 0.8%   52 Weeks 52.0%  
Cellavision AB Key Data:
  Ticker: CEVI Country: Sweden
  Exchanges: STO Major Industry: Health Care Equipment & Services
    Sub Industry: Electromedical Equipment
  2015 Sales 239,390,000
(Year Ending Jan 2016).
Employees: 75
  Currency: Swedish Kronor Market Cap: 2,248,008,305
  Fiscal Yr Ends: December Shares Outstanding: 23,851,547
  Share Type: Aktie Closely Held Shares: 4,984,974
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.